
Aug 20, 2025, 15:22
How Can We Better Manage GI Side Effects from New Cancer Therapies? | MASCC 2025
In this MASCC 2025 Conference episode, Dr. Christina Ruhlmann, a clinical oncologist from Denmark specializing in supportive care, shares key insights from her talk on emerging toxicities linked to ADCs, TKIs, and ICIs. Focusing on gastrointestinal toxicities such as diarrhea, colitis, nausea, and vomiting, Dr. Ruhlmann explains how understanding the differences in pathogenetic mechanisms is essential for selecting the right management approach for each drug class. She emphasizes the importance of equipping physicians and nurses with this knowledge to better manage these sometimes severe side effects.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 20, 2025, 15:20
Aug 20, 2025, 15:16
Aug 20, 2025, 15:09
Aug 20, 2025, 15:00
Aug 20, 2025, 14:46